Cellesce: Summary

Cellesce

Life Sciences, Biotechnology, Drug Discovery, Organoid Technology

Cellesce provides innovative solutions for the scaling and application of patient-derived organoids, enhancing drug discovery processes.

Cellesce specializes in the development and scaling of patient-derived organoids (PDOs) for drug discovery applications. Their proprietary bioprocess and bioreactors enable the expansion of both normal and cancer PDOs for various biotech and pharmaceutical uses.

Proprietary bioprocess for PDO expansion; Bespoke fee-for-service development and manufacturing; Full pipeline support for PDO technology; Research and development focused on expanding organoid applications

Cellesce's services are most valuable in drug screening, research and development in biotech and pharma, and bespoke organoid line development.

Strong focus on patient-derived organoids for drug discovery; Partnership with Molecular Devices, enhancing resources and market reach; Established pipeline of various organoid types for diverse applications

Cellesce's strengths include its innovative bioprocess technology, strong R&D capabilities, and strategic partnerships that enhance its market position.

Cellesce positions itself as a leader in the organoid technology space, providing essential tools and support for drug discovery.

The target users include biotech companies, pharmaceutical companies, and research institutions focused on drug discovery and development.

Learn more

• Patient-Derived Organoids

• Drug Discovery

• Bioprocessing

• Research and Development

Cellesce is now part of Molecular Devices

Professional, innovative, supportive

Cellesce's unique approach lies in its proprietary bioprocess and bioreactors specifically designed for the expansion of PDOs, which sets it apart from competitors in the organoid market.

Cellesce is identified as a cutting-edge innovator in the life sciences sector, particularly in the field of organoid technology.

2013-01-01

• Marianne Ellis